Ufibra: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
Ufibra
Largest movements
No asset line moved by more than 1% of the balance sheet total.
- Profit (loss) carried forward -€89,009
down €89,009 (-100%), from €89,009 to €0
- Reserves +€85,781
up €85,781 (+2.6%), from €3.3m to €3.4m
of which Distributable reserves: +€85,781
- Gross operating margin -€4.4m
down €4.4m, from €4.4m to -€2,388
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €4,604,985 | €4,602,477 | -€2,508 | -0.1% |
| Fixed assets | 21/28 | €1,500 | €1,500 | = | 0.0% |
| Tangible fixed assets | 22/27 | €0 | - | = | |
| Land and buildings | 22 | €0 | - | = | |
| Financial fixed assets | 28 | €1,500 | €1,500 | = | 0.0% |
| Current assets | 29/58 | €4,603,486 | €4,600,978 | -€2,508 | -0.1% |
| Amounts receivable within one year | 40/41 | €4,603,486 | €4,589,740 | -€13,745 | -0.3% |
| Other amounts receivable | 41 | €4,603,486 | €4,589,740 | -€13,745 | -0.3% |
| Cash at bank and in hand | 54/58 | €0 | €11,238 | +€11,238 | |
| Total equity and liabilities | 10/49 | €4,604,985 | €4,602,477 | -€2,508 | -0.1% |
| Equity | 10/15 | €3,497,689 | €3,494,460 | -€3,228 | -0.1% |
| Contributions | 10/11 | €62,000 | €62,000 | = | 0.0% |
| Reserves | 13 | €3,346,680 | €3,432,460 | +€85,781 | +2.6% |
| Non-distributable reserves | 130/1 | €24,789 | €24,789 | = | 0.0% |
| Reserves not available under the articles | 1311 | €0 | - | = | |
| Other | 1319 | €24,789 | €24,789 | = | 0.0% |
| Tax-exempt reserves | 132 | €3,321,890 | €3,321,890 | = | 0.0% |
| Distributable reserves | 133 | - | €85,781 | +€85,781 | |
| Profit (loss) carried forward | 14 | €89,009 | €0 | -€89,009 | -100% |
| Provisions and deferred taxes | 16 | €1,107,297 | €1,107,297 | = | 0.0% |
| Deferred taxes | 168 | €1,107,297 | €1,107,297 | = | 0.0% |
| Amounts payable | 17/49 | €0 | €721 | +€721 | |
| Amounts payable after more than one year | 17 | €0 | - | = | |
| Other amounts payable | 178/9 | €0 | - | = | |
| Amounts payable within one year | 42/48 | €0 | €721 | +€721 | |
| Trade debts | 44 | €0 | - | = | |
| Suppliers | 440/4 | €0 | - | = | |
| Taxes, remuneration and social security | 45 | €0 | - | = | |
| Taxes | 450/3 | €0 | - | = | |
| Other amounts payable | 47/48 | - | €721 | +€721 | |
| Accrued charges and deferred income | 492/3 | €0 | - | = | |
| Non-recurring operating income | 76A | €4,488,781 | €0 | -€4.5m | -100% |
| Other operating charges | 640/8 | €3,052 | €532 | -€2,520 | -82.6% |
| Gross operating margin | 9900 | €4,437,286 | -€2,388 | -€4.4m | |
| Operating profit (loss) | 9901 | €4,434,233 | -€2,920 | -€4.4m | |
| Financial income | 75/76B | €2 | €0 | -€2 | -100% |
| Recurring financial income | 75 | €2 | €0 | -€2 | -100% |
| Financial charges | 65/66B | €30 | €308 | +€278 | +927% |
| Recurring financial charges | 65 | €30 | €308 | +€278 | +927% |
| Profit (loss) for the period before taxes | 9903 | €4,434,205 | -€3,228 | -€4.4m | |
| Transfer to deferred taxes | 680 | €1,107,297 | €0 | -€1.1m | -100% |
| Income taxes | 67/77 | €1,255 | €0 | -€1,255 | -100% |
| Profit (loss) for the period | 9904 | €3,325,654 | -€3,228 | -€3.3m | |
| Transfer to tax-exempt reserves | 689 | €3,321,890 | €0 | -€3.3m | -100% |
| Profit (loss) for the period to be appropriated | 9905 | €3,764 | -€3,228 | -€6,992 |
Source: filed annual accounts (NBB), financial years ended 30 September 2024 and 30 September 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 16 October 2026 via checked.be.